Parametric Portfolio Associates’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$119K Buy
1,193
+10
+0.8% +$1.17K ﹤0.01% 3534
2021
Q4
$184K Sell
1,183
-160
-12% -$31.1K ﹤0.01% 3442
2021
Q3
$317K Sell
1,343
-96
-7% -$28K ﹤0.01% 3278
2021
Q2
$489K Sell
1,439
-153
-10% -$57.9K ﹤0.01% 3094
2021
Q1
$644K Buy
1,592
+678
+74% +$329K ﹤0.01% 3373
2020
Q4
$608K Buy
914
+120
+15% +$66.7K ﹤0.01% 3291
2020
Q3
$370K Sell
794
-3
-0.4% -$1.52K ﹤0.01% 3401
2020
Q2
$466K Buy
797
+213
+36% +$72.7K ﹤0.01% 3309
2020
Q1
$85K Buy
584
+50
+9% +$8.74K ﹤0.01% 3753
2019
Q4
$76K Sell
534
-1,795
-77% -$131K ﹤0.01% 3891
2019
Q3
$92K Sell
2,329
-2,586
-53% -$188K ﹤0.01% 3845
2019
Q2
$498K Buy
4,915
+214
+5% +$25.2K ﹤0.01% 3367
2019
Q1
$618K Buy
4,701
+78
+2% +$9.81K ﹤0.01% 3243
2018
Q4
$472K Buy
4,623
+2,038
+79% +$322K ﹤0.01% 3338
2018
Q3
$646K Buy
2,585
+821
+47% +$275K ﹤0.01% 3315
2018
Q2
$787K Buy
1,764
+365
+26% +$160K ﹤0.01% 3166
2018
Q1
$552K Buy
1,399
+457
+49% +$180K ﹤0.01% 3293
2017
Q4
$387K Buy
942
+1
+0.1% +$436 ﹤0.01% 3450
2017
Q3
$407K Buy
+941
New +$371K ﹤0.01% 3542

Other funds holding MRSN